NNIT A/S: 14/2015 Major shareholder announcement
(Thomson Reuters ONE) -
Company announcement 14/2015
Søborg/Copenhagen, 26 March 2015
Major shareholder announcement
With reference to announcement no. 8 dated 6 March 2015 regarding major
shareholder notification and announcement no. 12 dated 26 March 2015 regarding
exercise of the overallotment option in connection with the initial public
offering of shares in NNIT A/S (the "Overallotment Option"), NNIT A/S ("NNIT")
hereby announces the receipt of the following notification pursuant to Section
29 of the Danish Securities Trading Act regarding Novo Nordisk A/S ("Novo
Nordisk"), Novo A/S and the Novo Nordisk Foundation's respective direct and
indirect holdings of shares in NNIT.
In connection with the exercise of the Overallotment Option, the 1,500,000 NNIT
shares of a nominal value of DKK 10 each lent by Novo Nordisk to Danske Bank A/S
and Morgan Stanley & Co. International plc on behalf of the managers under the
stock lending agreement for the purposes of delivery of shares to investors as a
result of the Overallotment Option have today, 26 March 2015, been settled.
Following settlement of the Overallotment Option, Novo Nordisk has a direct
holding of shares in NNIT of 6,375,000 shares in total of a nominal value of DKK
10 each, corresponding to 25.5% of the share capital and 25.5% of the voting
rights in NNIT.
Novo Nordisk is a public limited company organised under the laws of Denmark
under CVR no. 24 25 67 90. Novo A/S is the parent company of Novo Nordisk
through its ownership of 26.46% of the total share capital and 73.97% of all
votes in Novo Nordisk. Novo A/S is a public limited company organised under the
laws of Denmark under CVR no. 24 25 76 30.
Following settlement of the Overallotment Option, Novo A/S has a direct and
indirect holding through Novo Nordisk of shares in NNIT of 12,750,000 shares in
total of a nominal value of DKK 10 each, corresponding to 51% of the share
capital and 51% of the voting rights in NNIT.
Novo A/S is wholly-owned by the Novo Nordisk Foundation. The Novo Nordisk
Foundation is a foundation organised under the laws of Denmark under CVR no.
10 58 29 89.
About NNIT
NNIT A/S is one of Denmark's leading IT service providers and consultancies.
NNIT A/S offers a wide range of IT services and solutions to its customers,
primarily in the life sciences sector in Denmark and internationally and to
customers in the public, enterprise and finance sectors in Denmark. As of 31
December 2014, NNIT A/S had more than 2,400 employees.
For more information please visit www.nnit.com.
Enquiries
Media contacts:
Robert Neimanas, Head of Communications: +45 3079 7480, rbnm(at)nnit.com
Investor contacts:
Jesper Wagener, Head of Investor Relations: +45 3075 5392, jvwa(at)nnit.com
14/2015 Major shareholder announcement :
http://hugin.info/163771/R/1906307/678631.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: NNIT A/S via GlobeNewswire
[HUG#1906307]
Unternehmensinformation / Kurzprofil:
Datum: 26.03.2015 - 15:33 Uhr
Sprache: Deutsch
News-ID 381403
Anzahl Zeichen: 3727
contact information:
Town:
Søborg
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 209 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NNIT A/S: 14/2015 Major shareholder announcement"
steht unter der journalistisch-redaktionellen Verantwortung von
NNIT A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
